Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleck Hercbergs

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Endocrinology|September 12, 2019
Clinical Implications and Impact of Discovery of the Thyroid Hormone Receptor on Integrin αvβ3-A ReviewAleck Hercbergs
Archives of Otolaryngology--Head & Neck Surgery|June 20, 2007
Hypothyroidism in the patient with cancer: how much thyroid supplementation is "safe"?Aleck Hercbergs, Paul Davis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Fewer dollars, more senseDavid H Garfield, Aleck Hercbergs
Nature Clinical Practice. Oncology|October 24, 2007
Unanswered questions regarding the management of sunitinib-induced hypothyroidismDavid Garfield, Aleck Hercbergs, Paul Davis
Medical Oncology (Northwood, London, England)|May 1, 2008
Management of hypothyroidism after radiotherapy for nasopharyngeal carcinomaDavid H Garfield, Aleck Hercbergs, Paul Davis
Frontiers in Endocrinology|January 21, 2026
Thyroid hormones, mitochondria, aging, and cancerGennadi Glinsky, Aleck Hercbergs, Paul J Davis
Archives of Otolaryngology--Head & Neck Surgery|October 18, 2006
Association between development of hypothyroidism and improved survival in patients with head and neck cancerMarc Nelson, Aleck Hercbergs, Lisa Rybicki, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin αvβ3Aleck Hercbergs, Shaker A Mousa, Paul J Davis
Journal of the National Cancer Institute|June 15, 2007
Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinibDavid H Garfield, Aleck Hercbergs, Paul J Davis
Cancer Biomarkers : Section a of Disease Markers|November 11, 2017
Plasma 3,3',5-Triiodo-L-thyronine [T3] level mirrors changes in tumor markers in two cases of metastatic cancer of the breast and pancreas treated with exogenous L-T3Alejandro Rodríguez-Molinero, Aleck Hercbergs, Manuel Sarrias, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Endocrinology|September 12, 2019
Clinical Implications and Impact of Discovery of the Thyroid Hormone Receptor on Integrin αvβ3-A ReviewAleck Hercbergs
Archives of Otolaryngology--Head & Neck Surgery|June 20, 2007
Hypothyroidism in the patient with cancer: how much thyroid supplementation is "safe"?Aleck Hercbergs, Paul Davis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Fewer dollars, more senseDavid H Garfield, Aleck Hercbergs
Nature Clinical Practice. Oncology|October 24, 2007
Unanswered questions regarding the management of sunitinib-induced hypothyroidismDavid Garfield, Aleck Hercbergs, Paul Davis
Medical Oncology (Northwood, London, England)|May 1, 2008
Management of hypothyroidism after radiotherapy for nasopharyngeal carcinomaDavid H Garfield, Aleck Hercbergs, Paul Davis
Frontiers in Endocrinology|January 21, 2026
Thyroid hormones, mitochondria, aging, and cancerGennadi Glinsky, Aleck Hercbergs, Paul J Davis
Archives of Otolaryngology--Head & Neck Surgery|October 18, 2006
Association between development of hypothyroidism and improved survival in patients with head and neck cancerMarc Nelson, Aleck Hercbergs, Lisa Rybicki, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin αvβ3Aleck Hercbergs, Shaker A Mousa, Paul J Davis
Journal of the National Cancer Institute|June 15, 2007
Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinibDavid H Garfield, Aleck Hercbergs, Paul J Davis
Cancer Biomarkers : Section a of Disease Markers|November 11, 2017
Plasma 3,3',5-Triiodo-L-thyronine [T3] level mirrors changes in tumor markers in two cases of metastatic cancer of the breast and pancreas treated with exogenous L-T3Alejandro Rodríguez-Molinero, Aleck Hercbergs, Manuel Sarrias, et al.
Pageof 6